Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...
Scientists have developed a scalable method to produce porous graphene membranes that efficiently separate carbon dioxide. The breakthrough could significantly reduce the cost and footprint of carbon ...
Researchers shifted the focus to the internal properties of the membrane itself, specifically its viscosity, highlighting its critical role in controlling deformation and dynamics during essential ...
Dr Michael Chen, CEO and co‑founder of Nuclera, said: “Scientists are under pressure to progress increasingly complex membrane protein programs faster. By partnering with leadXpro, we can pair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results